Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANGIODYNAMICS INC Director's Dealing 2015

Jul 24, 2015

32939_dirs_2015-07-24_da231513-40e2-42f2-85c9-415f5c052640.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2015-07-22

Reporting Person: Gould Kevin J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-07-22 Common Stock A 5266 Acquired 27025 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-07-22 Non-Qualified Stock Option (right to buy) $15.95 A 6022 Acquired 2022-07-22 Common Stock (6022) Direct

Footnotes

F1: The acquisition of 5,266 shares of common stock represents 5,266 restricted stock units, each of which represents a contingent right to receive one share of AngioDynamics, Inc. common stock. The restricted stock units vest in three equal installments beginning on 07/22/2016.

F2: Options for 33 1/3% of the shares are each exercisable on 07/22/2016, 07/22/2017 and 07/22/2018, respectively.